Vitamin D supplementation and COVID-19 risk: a population-based, cohort study.

Joaquim Oristrell J C Oliva Enrique Casado Burgos I Subirana Didier Domínguez Andrea Toloba Lopez-EgeaA BaladoMaria Grau

Published in: Journal of endocrinological investigation (2021)

In this large, population-based study, we observed that patients supplemented with cholecalciferol or calcifediol achieving serum 25OHD levels ≥ 30 ng/ml were associated with better COVID-19 outcomes.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
respiratory syndrome coronavirus
patient reported outcomes
adipose tissue
metabolic syndrome
glycemic control